Atypical Antipsychotics: Mechanism of Action
暂无分享,去创建一个
[1] S. Kapur,et al. Antipsychotic agents differ in how fast they come off the dopamine D2 receptors. Implications for atypical antipsychotic action. , 2000, Journal of psychiatry & neuroscience : JPN.
[2] Christer Halldin,et al. Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: A double-blind PET study of schizophrenic patients , 1993, Biological Psychiatry.
[3] P. Seeman,et al. Brain receptors for antipsychotic drugs and dopamine: direct binding assays. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[4] P. Seeman,et al. Antipsychotic drug doses and neuroleptic/dopamine receptors , 1976, Nature.
[5] G McKay,et al. PET evidence that loxapine is an equipotent blocker of 5-HT2 and D2 receptors: implications for the therapeutics of schizophrenia. , 1997, The American journal of psychiatry.
[6] P. Seeman,et al. Rapid release of antipsychotic drugs from dopamine D2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine. , 1999, The American journal of psychiatry.
[7] S. Kasper,et al. Sertindole and dopamine D2 receptor occupancy in comparison to risperidone, clozapine and haloperidol – a 123I-IBZM SPECT study , 1998, Psychopharmacology.
[8] P. Goldman-Rakic,et al. The cerebral cortex: a case for a common site of action of antipsychotics. , 1998, Trends in pharmacological sciences.
[9] L. Farde,et al. PET Analysis Indicates Atypical Central Dopamine Receptor Occupancy in Clozapine-Treated Patients , 1992, British Journal of Psychiatry.
[10] P. Seeman,et al. Atypical Neuroleptics Have Low Affinity for Dopamine D2 Receptors or Are Selective for D4 Receptors , 1997, Neuropsychopharmacology.
[11] A. Malhotra,et al. D2 dopamine receptor occupancy: a crossover comparison of risperidone with clozapine therapy in schizophrenic patients. , 1997, Archives of general psychiatry.
[12] A. Carlsson,et al. EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN. , 2009, Acta pharmacologica et toxicologica.
[13] C. Halldin,et al. Positron Emission Tomography of in-vivo Binding Characteristics of Atypical Antipsychotic Drugs , 1996, British Journal of Psychiatry.
[14] D. Pickar. Prospects for pharmacotherapy of schizophrenia , 1995, The Lancet.
[15] G. Sedvall,et al. Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. , 1992, Archives of general psychiatry.
[16] Alan A. Wilson,et al. The D2 Receptor Occupancy Profile of Loxapine Determined Using PET , 1996, Neuropsychopharmacology.
[17] H. Meltzer,et al. Effects of antipsychotic drugs on serotonin receptors. , 1991, Pharmacological reviews.
[18] G. Vankar,et al. Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia , 2001, Schizophrenia Research.
[19] P. Seeman,et al. Dopamine and serotonin receptors: amino acid sequences, and clinical role in neuroleptic parkinsonism. , 1996, Japanese journal of pharmacology.
[20] M. Albus,et al. D2‐dopamine receptor occupancy differs between patients with and without extrapyramidal side effects , 1994, Acta psychiatrica Scandinavica.
[21] P. Seeman. Tardive dyskinesia, dopamine receptors, and neuroleptic damage to cell membranes. , 1988, Journal of clinical psychopharmacology.
[22] S. Kasper,et al. IBZM SPECT imaging of striatal dopamine-2 receptors in psychotic patients treated with the novel antipsychotic substance quetiapine in comparison to clozapine and haloperidol , 1997, Psychopharmacology.
[23] C. Halldin,et al. Positron emission tomography studies on D2 dopamine receptor occupancy and plasma antipsychotic drug levels in man , 1995, International clinical psychopharmacology.
[24] M A Geyer,et al. 5-hydroxytryptamine2A receptor inverse agonists as antipsychotics. , 2001, The Journal of pharmacology and experimental therapeutics.
[25] P. Seeman. Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4. , 1992, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.
[26] S. Kapur,et al. A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy. , 2000, Archives of general psychiatry.
[27] G. Sedvall,et al. D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics , 2004, Psychopharmacology.
[28] A. Labelle,et al. Phase-IV Multicentre Clinical Study of Risperidone in the Treatment of Outpatients with Schizophrenia , 1998, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[29] H. Meltzer,et al. Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values. , 1989, The Journal of pharmacology and experimental therapeutics.
[30] J. Martinot,et al. Binding of antipsychotic drugs to cortical 5-HT2A receptors: a PET study of chlorpromazine, clozapine, and amisulpride in schizophrenic patients. , 1998, The American journal of psychiatry.
[31] S. Kasper,et al. 63-2 Sertindole and dopamine D2 receptor occupancy , 1997, Biological Psychiatry.
[32] Alan A. Wilson,et al. The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: a PET study. , 1995, Life sciences.
[33] S H Snyder,et al. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs , 1976, Science.
[34] U. Ungerstedt,et al. Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. , 1970, European journal of pharmacology.
[35] L. Cervo,et al. 8-hydroxy-2-(di-N-propylamino) tetralin, a selective serotonin1A receptor agonist, blocks haloperidol-induced catalepsy by an action on raphe nuclei medianus and dorsalis , 1988, Neuropharmacology.
[36] J. Browning,et al. Antagonism at 5-HT2A receptors potentiates the effect of haloperidol in a conditioned avoidance response task in rats , 2001, Pharmacology Biochemistry and Behavior.
[37] P. Seeman,et al. Antipsychotic drugs which elicit little or no Parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors , 1998, Molecular Psychiatry.
[38] N. Andén,et al. Effects of chlorpromazine, haloperidol and reserpine on the levels of phenolic acids in rabbit corpus striatum☆ , 1964 .
[39] L. Steardo,et al. New Insights into the Biology of Schizophrenia through the Mechanism of Action of Clozapine , 1995, Neuropsychopharmacology.
[40] Alan A. Wilson,et al. 5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation. , 1998, The American journal of psychiatry.
[41] S. Kapur,et al. Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis. , 2001, The American journal of psychiatry.